Literature DB >> 21868760

Pivotal role of reduced let-7g expression in breast cancer invasion and metastasis.

Pengxu Qian1, Zehua Zuo, Zhengsheng Wu, Xianyi Meng, Gaopeng Li, Zhengzhou Wu, Weijie Zhang, Sheng Tan, Vijay Pandey, Yandan Yao, Puyue Wang, Liqing Zhao, Jun Wang, Qiang Wu, Erwei Song, Peter E Lobie, Zhinan Yin, Tao Zhu.   

Abstract

Screening of the entire let-7 family of microRNAs (miRNA) by in situ hybridization identified let-7g as the only member, the diminished expression of which was significantly associated with lymph node metastasis and poor survival in breast cancer patients. Abrogation of let-7g expression in otherwise nonmetastatic mammary carcinoma cells elicited rapid metastasis from the orthotopic location, through preferential targets, Grb2-associated binding protein 2 (GAB2) and fibronectin 1 (FN1), and consequent activation of p44/42 mitogen-activated protein kinase (MAPK) and specific matrix metalloproteinases. Treatment with estrogen or epidermal growth factor specifically reduced the expression of mature let-7g through activation of p44/42 MAPK and subsequently stimulated expression of GAB2 and FN1, which, in turn, promoted tumor invasion. We thus identify let-7g as a unique member of the let-7 miRNA family that can serve as a prognostic biomarker in breast cancer and also propose a paradigm used by specific signaling molecules via let-7g to cooperatively promote breast cancer invasion and metastasis. Thus, let-7 family members neither possess equivalent clinicopathologic correlation nor function in breast cancer.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21868760     DOI: 10.1158/0008-5472.CAN-11-1322

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  70 in total

1.  Autocrine/Paracrine Human Growth Hormone-stimulated MicroRNA 96-182-183 Cluster Promotes Epithelial-Mesenchymal Transition and Invasion in Breast Cancer.

Authors:  Weijie Zhang; Pengxu Qian; Xiao Zhang; Min Zhang; Hong Wang; Mingming Wu; Xiangjun Kong; Sheng Tan; Keshuo Ding; Jo K Perry; Zhengsheng Wu; Yuan Cao; Peter E Lobie; Tao Zhu
Journal:  J Biol Chem       Date:  2015-04-14       Impact factor: 5.157

Review 2.  GAB2--a scaffolding protein in cancer.

Authors:  Sarah J Adams; Iraz T Aydin; Julide T Celebi
Journal:  Mol Cancer Res       Date:  2012-08-07       Impact factor: 5.852

Review 3.  Regulation of microRNAs in cancer metastasis.

Authors:  Juliette M C Bouyssou; Salomon Manier; Daisy Huynh; Samar Issa; Aldo M Roccaro; Irene M Ghobrial
Journal:  Biochim Biophys Acta       Date:  2014-02-22

Review 4.  Non-coding RNAs as theranostics in human cancers.

Authors:  Roxana S Redis; Ioana Berindan-Neagoe; Victor I Pop; George A Calin
Journal:  J Cell Biochem       Date:  2012-05       Impact factor: 4.429

5.  Circulating microRNA profiles reflect the presence of breast tumours but not the profiles of microRNAs within the tumours.

Authors:  Victoria J Cookson; Michael A Bentley; Brian V Hogan; Kieran Horgan; Bruce E Hayward; Lee D Hazelwood; Thomas A Hughes
Journal:  Cell Oncol (Dordr)       Date:  2012-07-21       Impact factor: 6.730

Review 6.  miRNAs and estrogen action.

Authors:  Carolyn M Klinge
Journal:  Trends Endocrinol Metab       Date:  2012-04-11       Impact factor: 12.015

7.  Inferred miRNA activity identifies miRNA-mediated regulatory networks underlying multiple cancers.

Authors:  Eunjee Lee; Koichi Ito; Yong Zhao; Eric E Schadt; Hanna Y Irie; Jun Zhu
Journal:  Bioinformatics       Date:  2015-09-10       Impact factor: 6.937

8.  The heterochronic microRNA let-7 inhibits cell motility by regulating the genes in the actin cytoskeleton pathway in breast cancer.

Authors:  Xiaowen Hu; Jinyi Guo; Lan Zheng; Chunsheng Li; Tim M Zheng; Janos L Tanyi; Shun Liang; Chiara Benedetto; Marco Mitidieri; Dionyssios Katsaros; Xia Zhao; Youcheng Zhang; Qihong Huang; Lin Zhang
Journal:  Mol Cancer Res       Date:  2013-01-21       Impact factor: 5.852

9.  Regulation of tumor cell migration and invasion by the H19/let-7 axis is antagonized by metformin-induced DNA methylation.

Authors:  L Yan; J Zhou; Y Gao; S Ghazal; L Lu; S Bellone; Y Yang; N Liu; X Zhao; A D Santin; H Taylor; Y Huang
Journal:  Oncogene       Date:  2014-08-04       Impact factor: 9.867

10.  DEAD-box helicase DP103 defines metastatic potential of human breast cancers.

Authors:  Eun Myoung Shin; Hui Sin Hay; Moon Hee Lee; Jen Nee Goh; Tuan Zea Tan; Yin Ping Sen; See Wee Lim; Einas M Yousef; Hooi Tin Ong; Aye Aye Thike; Xiangjun Kong; Zhengsheng Wu; Earnest Mendoz; Wei Sun; Manuel Salto-Tellez; Chwee Teck Lim; Peter E Lobie; Yoon Pin Lim; Celestial T Yap; Qi Zeng; Gautam Sethi; Martin B Lee; Patrick Tan; Boon Cher Goh; Lance D Miller; Jean Paul Thiery; Tao Zhu; Louis Gaboury; Puay Hoon Tan; Kam Man Hui; George Wai-Cheong Yip; Shigeki Miyamoto; Alan Prem Kumar; Vinay Tergaonkar
Journal:  J Clin Invest       Date:  2014-08-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.